Streetbeat News

Stock Prices

RIVN

Rivian Automotive has an option alert for October 20 $37.5 calls at the ask price of $1.25 for 400 shares, compared to an open interest of 1455. The company's earnings will be announced after close on August 8. The reference price is $26.09.

Portfolio Pulse from Charles Gross

July 24, 2023 | 6:22 pm

AXP

YOU

Clear Secure Inc's stock is trading higher after Needham analyst Joshua Reilly reiterated a Buy recommendation with a $40 price target. The analyst believes that the company's growth is more sustainable than investors expect and profitability at scale will also surprise the upside. Key bull points include the sustainability of the travel boom post-COVID-19, a large enough TAM to double subscribers over time, and attractive unit economics driving long-term FCF leverage. The analyst also noted that the valuation of Clear Secure at 20x EV/FCF based on the FY23 consensus estimate discounts a slowdown in travel and Amex bookings.

Portfolio Pulse from Anusuya Lahiri

July 24, 2023 | 6:20 pm

RF

Regions Financial Corp (NYSE:RF) reported mixed Q2 2023 results, with revenue growth of 12% Y/Y to $1.957 billion, beating the consensus of $1.95 billion, and EPS of $0.59, in line with the consensus. Analysts from DA Davidson, Morgan Stanley, RBC Capital, and Wedbush have revised their price targets and EPS estimates for the company. RF shares are trading higher by 1.83% at $20.08.

Portfolio Pulse from Lekha Gupta

July 24, 2023 | 6:17 pm

SLB

Susquehanna analyst Charles P. Minervino has reiterated a Positive rating on Schlumberger N.V. (NYSE:SLB), raising the price target to $68 from $65. The analyst is bullish about long-term demand from the Middle East, which he sees as a compelling opportunity for SLB. Despite a slight miss on Q2 FY23 revenue, SLB reported a 19.6% YoY increase to $8.10 billion and a 44% YoY increase in adjusted EPS to $0.72. Minervino expects SLB to play a key role in global energy trends and sees a long-term runway for earnings growth.

Portfolio Pulse from Nabaparna Bhattacharya

July 24, 2023 | 6:15 pm

INTU

A significant bearish stance has been taken on Intuit (NASDAQ:INTU) by a large investor or institution, as indicated by unusual options trading activity. The sentiment among these big-money traders is 75% bearish and 25% bullish. The whales have been targeting a price range from $440.0 to $570.0 for Intuit over the last 3 months. Exane BNP Paribas upgraded its action to Neutral with a price target of $532, while Keybanc maintained their Overweight rating on Intuit with a price target of $525.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 6:15 pm

CAT

A significant bearish stance has been taken on Caterpillar (NYSE:CAT) by a large investor, as observed from publicly available options history. Benzinga's options scanner spotted 11 uncommon options trades for Caterpillar, with the sentiment of these big-money traders being 18% bullish and 81% bearish. Whales have been targeting a price range from $200.0 to $320.0 for Caterpillar over the last 3 months. Citigroup has maintained their Neutral rating on Caterpillar, with a price target of $270.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 6:15 pm

HAL

A significant amount of unusual options activity has been observed for Halliburton (NYSE:HAL), with a bearish stance being taken by a majority of investors. Whales have been targeting a price range from $23.0 to $40.0 for Halliburton over the last 3 months. The price of HAL is currently up 3.6% at $38.27. Analysts from Raymond James, Citigroup, Stifel, and Morgan Stanley have given their ratings and price targets for the company.

Portfolio Pulse from Benzinga Insights

July 24, 2023 | 6:15 pm

MRK

NRIX

HC Wainwright analyst Robert Burns has lowered the price target for Nurix Therapeutics Inc (NRIX) from $53 to $33, citing higher operating expenses and a decrease in the terminal growth rate. This comes after Nurix presented clinical and preclinical data from its targeted protein degradation programs, NX-5948 and NX-2127. The analysts also compared Nurix's results with Merck & Co Inc's (MRK) BELLWAVE-001 trial results, noting that nemtabrutinib's response rate is highly encouraging.

Portfolio Pulse from Vandana Singh

July 24, 2023 | 6:14 pm

MSFT

SPLK

Splunk Inc's user conference showcased advancements in AI and a strategic collaboration with Microsoft. The event highlighted a change of pace from last year, with a greater number of product announcements and increased internal R&D innovation. Analysts from Needham and JMP maintained a Buy and Market Perform rating respectively, despite expressing caution about Splunk's overall competitive positioning. SPLK shares are trading lower by 1.29% at $103.12.

Portfolio Pulse from Anusuya Lahiri

July 24, 2023 | 6:07 pm

AAPL

The article discusses five counterintuitive concepts in investing: the role of luck in skill-based activities like investing, the importance of understanding the value of a stock rather than just its price, the potential benefits of investing during market downturns, the unreliability of market forecasts, and the fact that high intelligence is not a prerequisite for successful investing. Apple Inc. (NASDAQ:AAPL) is mentioned as an example of a stock whose price needs to be evaluated against its future value.

Portfolio Pulse from Cosmo P. DeStefano

July 24, 2023 | 6:07 pm